Pharma major Biocon slipped by 5 per cent in Thursday’s trade as the United States Food and Drugs Association issued a Form 483 with 7 observation for the company’s Bengaluru manufacturing unit. 

The markets on May 3, 2018 opened down. BSE Sensex is trading at 35,085.37, down by 91.05 points and the Nifty is trading at 10,668.30, down by 49.75 points. 

During the quarter, the company’s net profit jumped to Rs. 102.8 crore from merely Rs. 17.2 crore in the corresponding quarter of last year.

Kridhan Infra’s subsidiary, Swee Hong has successfully won order worth Rs. 56.6 crore (SG$11.3 million) in Singapore. Swee Hong has secured these contracts from the Public Utilities Board for work in respect of proposed sewers in Punggol North Area.

Delhi High Court heard PILs alleging that Adani Enterprises indulged in the scam of over-invoicing of power-equipment in order to get undue access to credit facilities from six PSU banks.

Overall volumes in futures & options currently stand at 73.29 lakh contracts with a turnover of Rs. 6,80,406.73 crore.

Overall volumes in futures & options currently stand at 73.29 lakh contracts with a turnover of Rs. 6,80,406.73 crore.

In the coming session, the level of 10,630 would act as a strong short term support for the index and, on the higher side, the level of 10,780-10,800 is likely to act as a strong resistance. Stocks in the news: Biocon, Lemon Tree Hotels, Infosys, Cadila Healthcare, Power Grid, Techno Electric, Kridhan Infra, Sical Logistics, Infibeam Corporation and Adani Transmission.

Key Indian equity indices are likely to open in red on the back of broadly negative Asian cues. The SGX Nifty is indicating that Nifty may open with a loss of 41 points at 10,716. 

 Pharma major Zydus Cadila received final approval for Bumetanide Tablets USP from the US Food and Drug Administration (USFDA) on Wednesday, post market hours.